Legal & General Group PLC Monte Rosa Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 15,803 shares of GLUE stock, worth $81,701. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,803
Previous 15,803 -0.0%
Holding current value
$81,701
Previous $111,000 46.85%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$4.26 - $8.46 $18,594 - $36,927
-4,365 Reduced 21.64%
15,803 $111,000
Q4 2023

Feb 15, 2024
SELL
$2.5 - $5.93 $36,142 - $85,730
-14,457 Reduced 41.75%
20,168 $113,000
Q3 2023

Nov 14, 2023
BUY
$4.78 - $7.22 $30,921 - $46,706
6,469 Added 22.98%
34,625 $165,000
Q2 2023

Aug 14, 2023
BUY
$4.53 - $8.4 $90,314 - $167,470
19,937 Added 242.57%
28,156 $192,000
Q1 2023

May 15, 2023
BUY
$5.95 - $8.21 $4,646 - $6,412
781 Added 10.5%
8,219 $64,000
Q4 2022

Feb 14, 2023
BUY
$6.71 - $9.72 $2,576 - $3,732
384 Added 5.44%
7,438 $56,000
Q3 2022

Nov 14, 2022
BUY
$7.17 - $12.16 $932 - $1,580
130 Added 1.88%
7,054 $57,000
Q2 2022

Aug 22, 2022
BUY
$6.15 - $14.99 $11,875 - $28,945
1,931 Added 38.67%
6,924 $67,000
Q1 2022

May 16, 2022
BUY
$10.36 - $20.41 $17,363 - $34,207
1,676 Added 50.53%
4,993 $70,000
Q4 2021

Feb 14, 2022
BUY
$16.28 - $27.15 $36,385 - $60,680
2,235 Added 206.56%
3,317 $68,000
Q3 2021

Nov 15, 2021
SELL
$18.59 - $42.21 $35,655 - $80,958
-1,918 Reduced 63.93%
1,082 $24,000
Q2 2021

Aug 12, 2021
BUY
$18.86 - $22.7 $56,580 - $68,100
3,000 New
3,000 $69,000

Others Institutions Holding GLUE

# of Institutions
77
Shares Held
40.6M
Call Options Held
84.2K
Put Options Held
20.6K
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $242M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email